CARE™ Access to Innovation Position Statement

Access to Innovation



19 Mar 2018

 Members of the CARE™ Hematology and Oncology Faculty met at ASCO (Chicago, June); EHA (Stockholm, June) and CUA (Halifax, June) to consider a CARE™ position statement regarding access to innovative therapies in Canada. These working groups were augmented with ad hoc sessions in Toronto and Hamilton for faculty who were unable to attend these sessions.